Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 50, pseudogene (RN7SL50P) is a human genomic locus classified as a pseudogene of the 7SL RNA, which is the RNA component of the signal recognition particle (SRP)[1][6]. The SRP is essential for co-translational protein targeting to the endoplasmic reticulum, with 7SL RNA acting as its structural and functional core[5]. RN7SL50P is not an expressed protein-coding gene but a truncated, non-functional copy of 7SL RNA that arose by retrotransposition[4][6]. Such pseudogenes are abundant in the genome and lack known biological function, therapeutic relevance, or direct disease association[1][4][6]. They do not serve as therapeutic targets and have no described roles in drug interaction, biomarker development, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 50, pseudogene (RN7SL50P).